Other neurodevelopmental disorders of interest in the lab include autism-spectrum disorders and schizophrenia. We have a long-standing interest in modeling Parkinson’s disease (PD) using human iPSC ...

A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...

Patients' own stem cells to replace damaged dopamine cells in Parkinson’s disease, offering new hope. Parkinson's disease - ...

A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem ...

DUBLIN--(BUSINESS WIRE)--The "Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, & Forecasts, 2025" report has been added to ResearchAndMarkets.com's offering. Since the ...